(203 days)
Not Found
No
The device description details a mechanical tracheostomy tube and its accessories. There is no mention of software, data processing, or any features that would suggest the use of AI or ML.
Yes
The device is used to maintain an airway for tracheostomized patients, which is a therapeutic intervention.
No
Explanation: The device description and intended use indicate that the Portex Blue Line Ultra Tracheostomy Tube is used for airway maintenance and providing an airway for ventilation, not for diagnosing any medical condition.
No
The device description clearly details a physical tracheostomy tube, including materials, sizes, components (cuff, inner cannula, obturator), and packaging. It is a hardware medical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "airway maintenance of Tracheostomised patients." This describes a device used in vivo (within the body) to maintain an airway.
- Device Description: The description details a physical tube inserted into the trachea to facilitate breathing. It describes mechanical functions like providing an airway, sealing the trachea, and allowing for cleaning.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or compatibility testing.
IVD devices are used in vitro (outside the body) to analyze biological samples. This device is clearly used in vivo to manage a patient's airway.
N/A
Intended Use / Indications for Use
Portex Blue Line Ultra Tracheostomy Tube is indicated for airway maintenance of tracheostomised patients.
Product codes (comma separated list FDA assigned to the subject device)
BTO
Device Description
The Blue Line Ultra (BLU) tracheostomy tube provides an airway to the patients lungs when the upper airway / larynx / pharynx or oral & nasal routes are occluded or compromised due to traumatic injury, illness, or during surgery, and is elective for long term ventilated patients. The tube can be used for ventilated, or spontaneously breathing patients.
The BLU is available in sizes 6.0, 7.0, 7.5, 8.0, 8.5 and 9.0mm only.
BLU is available in cuffed and uncuffed variants. The cuff provides a seal against the trachea, ensuring that inspiratory and expiatory gasses are routed through the tube and not allowed to escape to the patients upper airway, thus preventing loss of ventilation / anaesthetic and nebulised drugs, and reducing the likelihood of any aspirated stomach contents from entering the lungs. Uncuffed tubes are used when patients require less protection from loss of ventilation / anaesthetic and nebulised drugs and or stomach aspiration.
The outer tube can be used with or without an inner cannula lines the bore of the outer tube, and can be removed, cleaned and replaced to ensure that the bore of the tube is kept patent.
The BLU is supplied pre-loaded onto an obturator. The obturator reduces the risk of the distal end of the product from damaging the trachea upon insertion. The obturator has an internal pathway for a guide wire, so that a guide wire can be used to help position the tube through the stoma site for tube change insertion.
The BLU tracheostomy tube is packed in several kit variants to suit clinician preferences. Each kit contains a tracheostomy tube holder, an inner cannula cleaning brush, disconnection wedge and a patient notes label. The change kit includes a tube change i tip guide wire. This wire is used to help place a second tracheostomy tube in a pre-existing stoma when the first tube needs to be changed. Each kit is individually packed in a blister and shelf carton (tracheostomy tube holder and cleaning bush packed outside of the blister in a polyethylene bag), and the products are sterile by ETO.
Replacement Blue Line Ultra inner cannula are available in packs of 20 or 50. The cannula are individually packed in a blister to maintain sterility, and contained within a shelf carton. The inner cannula lines the bore of the outer tube, and can be removed, cleaned and replaced to ensure that the bore of the tube is kept patent.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
airway, larynx, pharynx, oral & nasal routes, trachea
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance data for the proposed device is shown in section 8.0 Performance.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K912124, K811033, K980466, K923559
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.5800 Tracheostomy tube and tube cuff.
(a)
Identification. A tracheostomy tube and tube cuff is a device intended to be placed into a surgical opening of the trachea to facilitate ventilation to the lungs. The cuff may be a separate or integral part of the tracheostomy tube and is, when inflated, intended to establish a seal between the tracheal wall and the tracheostomy tube. The cuff is used to prevent the patient's aspiration of substances, such as blood or vomit, or to provide a means for positive-pressure ventilation of the patient. This device is made of either stainless steel or plastic.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image shows a close-up of a handwritten code or identifier, "K030381", written in a bold, slightly tilted font. The characters are large and clearly legible, with a handwritten style that gives them a personal touch. The background is plain white, which helps the code stand out.
Portex Ltd. Blue Line Ultra Tracheostomy Kits. 510(K) Notification
AUG 2 7 2003
SECTION 5.0 : 510K SUMMARY
DATE SUBMITTED: 22 August 2003
SUBMITTER: Portex Ltd Hythe Kent England, CT21 6JL
CONTACT PERSON: Mr Steve Ogilvie, Regulatory and Scientific Affairs Director, Portex Ltd, Military Road, Hythe, Kent, England. CT21 6DB Phone 00 44 (0)1303 208011 Fax 00 44 (0)1303 262798
DEVICE NAME: Blue Line Ultra Tracheostomy Tube
COMMON NAME AND CLASSIFICATION: Tracheostomy tube. Class II BTO, 21 CFR 868.5800
PREDICATE DEVICES:
- Portex Inc Flexible D.I.C Tracheostomy tube, already marketed in the USA under K912124
- Shiley Low Pressure Cuffed Tracheostomy Tube with Reusable Inner Cannula, already marketed in the USA under K811033.
- Portex Inc. Percutaneous Dilatory tracheostomy Kit with Speciality tracheostomy Tube, already marketed in the USA under K980466
- . Portex Inc Steri-Cath Closed Ventilation Suction System already marketed in the USA under K923559
DEVICE DESCRIPTION:
The Blue Line Ultra (BLU) tracheostomy tube provides an airway to the patients lungs when the upper airway / larynx / pharynx or oral & nasal routes are occluded or compromised due to traumatic injury, illness, or during surgery, and is elective for long term ventilated patients. The tube can be used for ventilated, or spontaneously breathing patients.
The BLU is available in sizes 6.0, 7.0, 7.5, 8.0, 8.5 and 9.0mm only.
BLU is available in cuffed and uncuffed variants. The cuff provides a seal against the trachea, ensuring that inspiratory and expiatory gasses are routed through the tube and not allowed to escape to the patients upper airway, thus preventing loss of ventilation / anaesthetic and nebulised drugs, and reducing the likelihood of any aspirated stomach contents from entering the lungs. Uncuffed tubes are used when patients require less protection from loss of ventilation / anaesthetic and nebulised drugs and or stomach aspiration.
1
Portex Ltd. Blue Line Ultra Tracheostomy Kits. 510(K) Notification
SECTION 5.0 : 510K SUMMARY
The outer tube can be used with or without an inner cannula lines the bore of the outer tube, and can be removed, cleaned and replaced to ensure that the bore of the tube is kept patent.
The BLU is supplied pre-loaded onto an obturator. The obturator reduces the risk of the distal end of the product from damaging the trachea upon insertion. The obturator has an internal pathway for a guide wire, so that a guide wire can be used to help position the tube through the stoma site for tube change insertion.
The BLU tracheostomy tube is packed in several kit variants to suit clinician preferences. Each kit contains a tracheostomy tube holder, an inner cannula cleaning brush, disconnection wedge and a patient notes label. The change kit includes a tube change i tip guide wire. This wire is used to help place a second tracheostomy tube in a pre-existing stoma when the first tube needs to be changed. Each kit is individually packed in a blister and shelf carton (tracheostomy tube holder and cleaning bush packed outside of the blister in a polyethylene bag), and the products are sterile by ETO.
Replacement Blue Line Ultra inner cannula are available in packs of 20 or 50. The cannula are individually packed in a blister to maintain sterility, and contained within a shelf carton. The inner cannula lines the bore of the outer tube, and can be removed, cleaned and replaced to ensure that the bore of the tube is kept patent.
INTENDED USE:
Portex Blue Line Ultra Tracheostomy Tube is indicated for airway maintenance of tracheostomised patients.
TECHNOLOGICAL CHARICTUREISTICS OF PROPOSED VERSUS PREDICATE DEVICES:
- The proposed device is substantially equivalent to Predicate device 1 Portex Inc Flexible D.I.C . Tracheostomy tube (K912124), in all aspects except the following:
- Inner cannula. The basic design and materials of the inner cannula of Predicate 1 and the o proposed device are substantially equivalent. However, the inner cannula of Predicate I is disposable, where as the inner cannula of the proposed device can be removed from the tracheostomy tube, cleaned and replaced. The re-useable feature of the proposed device's inner cannulae is compared to Predicate 2.
- Tube change guide wire. The tube change guide wire is an additional component to Predicate o 1. This component will be compared to predicate device 3.
- Disconnection Wedge. The disconnection wedge is an additional component to Predicate 1. o This component will be compared to predicate device 4.
- . The re-useable feature of the proposed device's inner cannulae is substantially equivalent to Predicate 2 -Shiley Low Pressure Cuffed Tracheostomy Tube with Reusable Inner Cannula (K811033). Note, only the reusable nature of the inner cannula is compared.
- The tube change guide wire of the proposed device is substantially equivalent to Predicate 3 - Portex Inc. Percutaneous Dilatory tracheostomy Kit with Speciality tracheostomy Tube (K980466) Note, only the tube change guide wire is compared.
2
Portex Ltd. Blue Line Ultra Tracheostomy Kits. 510(K) Notification
SECTION 5.0 : 510K SUMMARY
PERFORMANCE / CLINICAL DATA:
Performance data for the proposed device is shown in section 8.0 Performance.
CONCLUSION:
Comparison of the proposed device to the predicate devices supports the conclusion that the proposed device is substantially equivalent in safety and effectiveness in its intended use to existing legally marketed devices.
3
Image /page/3/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services - USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract image of a human figure.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 2 7 2003
Mr. Steve Ogilvie Regulatory and Scientific Affairs Director Portex Limited Military Road Hythe. Kent ENGLAND CT21 6DB United Kingdom
Re: K030381
Trade/Device Name: Blue Line Ultra Tracheostomy Tube Regulation Number: 868.5800 Regulation Name: Tracheostomy Tube and tube Cuff Regulatory Class: II Product Code: BTO Dated: May 30, 2003 Received: June 2, 2003
Dear Mr. Ogilvie:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting vour device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Mr. Ogilvie
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Susan Runner
Susan Runner, DDS, MA Interim Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Portex Ltd . Blue Line Ultra Tracheostomy Kits, 510(K) Notification
Section 4.0: STATEMENT OF INDICATION FOR USE
510(K) Number (if known): K030381
Page 1 of 1
Device Name: Portex Blue Line Ultra Tracheostomy Tube
Indications for use:
'Portex Blue Line Ultra Tracheostomy Tube is indicated for airway maintenance of Tracheostomised patients'
signature
Division Sian-Off) ivision of Anesthesiology, General Hospital, Infection Control, Dental Devices
510(k) Number: K030381
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)